| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |